| ●Editorial | Tsubaki H | 340-1 | Full text | |
| ●Lecture | ||||
| The 12th Annual Meeting of the Japanese Association of Pharmaceutical Medicine 2021－A new style of pharmaceutical medicine (President: Kotone Matsuyama) ＜Keynote lecture＞ Clinical Practice for COVID-19 | Ohmagari N Chaired by Seriu T Graphic recording by Yoshikawa K Co-organized by EP-CRSU CO., LTD. |
343-60 | Abstract | |
| ●Round table discussion | ||||
| Perspectives for overcoming the COVID-19 pandemic: Science, society and medicine: the 2nd session －Overviewing our two-year experience－ | Tsubaki H，Funatogawa I，Saito M， Endo K，Kasanuki H Organized by Kurihara C，Saio T |
361-434 | Abstract | |
| ●Articles | ||||
| Statistical aspects of safety-related clinical assessment | Tsubaki H | 435-41 | Abstract | |
| Analysis of epidemiological data including an interaction in symptom occurrence －From the “Nagoya City Cervical Cancer Vaccination Survey” | Shitara S，Morikawa T | 443-81 | Full text | |
| Comparison between two papers analyzing data from the “Nagoya City Cervical Cancer Immunization Program Survey Results” | Yaju Y | 483-98 | Full text | |
| Overview of COVID-19 post-vaccination mortality and pharmacoepidemiological evaluation: nation-wide view and a proposal | Fukushima M，Hirai Y，Nakatani E， Nishimura T |
499-517 | Full text | |
| PTSD without trauma: to reconstruct stress-related disorders | Saio T | 519-30 | Full text | |
| ●Forum | ||||
| Bioethics Seminar organized by and for patient and public Civic Action to link the lives for our future | Kurihara C，Uchida E，Murakami T， Kai H，Suzuki K，Inoue K |
531-8 | Full text | |
| ●Instructions for authors［Japanese］＆［English］ | 541-9 | Full text | ||
| ●Editor’s note | Kurihara M | 551 | Full text | |